Shahin Lockman MD
Associate Professor, Medicine-Brigham & Women's Hospital, Harvard Medical
Join to View Full Profile
75 Francis St"# Brigham"Boston, MA 02115
Phone+1 617-732-5885
Are you Dr. Lockman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shahin Lockman, MD is an infectious disease specialist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is an Associate Professor at Harvard Medical.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1998 - 2001
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1993 - 1996
Northwestern University The Feinberg School of MedicineClass of 1993
Certifications & Licensure
MA State Medical License 1995 - 2026
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Neurodevelopmental outcomes in children exposed in utero to dolutegravir- or efavirenz-based antiretroviral treatment.Adam R Cassidy, Gloria Mayondi, Paige L Williams, Kebaiphe Moabi, Allison LeMahieu
AIDS. 2025-04-01 - Lipid and Glucose Profiles in Pregnant Women With HIV on Tenofovir-based Antiretroviral Therapy.Ahizechukwu C Eke, Sean S Brummel, Muktar H Aliyu, Lynda Stranix-Chibanda, George U Eleje
Clinical Infectious Diseases. 2025-03-17 - High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Franci...Ontlametse T Choga, Goitseone M Lemogang, Wonderful T Choga, Gaonyadiwe Muzanywa, Thembinkosi M Shadreck
The Journal of Antimicrobial Chemotherapy. 2025-03-03
Press Mentions
Global Vaccine Equity Is Within Reach if We Act NowSeptember 24th, 2021- Massachusetts Infectious Disease Doctors Say COVID-19 Booster Plan Is Too BroadAugust 19th, 2021
- Really Rapid Review — CROI 2021 VirtualMarch 14th, 2021
- Join now to see all
Grant Support
- Training in HIV Genomics, Treatment, and Cure Research in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2013–2028
- Training in HIV Genomics, Treatment, and Cure Research in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2013–2028
- Training in HIV Genomics, Treatment, and Cure Research in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2013–2028
- Training in HIV Genomics, Treatment, and Cure Research in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2013–2028
- Training in HIV Genomics, Treatment, and Cure Research in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2013–2028
- Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ARTBRIGHAM AND WOMEN'S HOSPITAL2017–2027
- Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ARTBRIGHAM AND WOMEN'S HOSPITAL2017–2027
- Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ARTBRIGHAM AND WOMEN'S HOSPITAL2017–2027
- Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ARTBRIGHAM AND WOMEN'S HOSPITAL2017–2027
- Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTUHARVARD SCHOOL OF PUBLIC HEALTH2007–2027
- Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTUHARVARD SCHOOL OF PUBLIC HEALTH2007–2027
- Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTUHARVARD SCHOOL OF PUBLIC HEALTH2007–2027
- Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTUHARVARD SCHOOL OF PUBLIC HEALTH2007–2027
- Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir Or EfavirenzHARVARD SCHOOL OF PUBLIC HEALTH2020–2026
- Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir Or EfavirenzHARVARD SCHOOL OF PUBLIC HEALTH2020–2026
- Training in HIV Genomics, Treatment, and Cure Research in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2024–2025
- Training in HIV Genomics, Treatment, and Cure Research in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2024–2025
- Training in HIV Genomics, Treatment, and Cure Research in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2024–2025
- Training in HIV Genomics, Treatment, and Cure Research in BotswanaHARVARD SCHOOL OF PUBLIC HEALTH2024–2025
